Bucketh..., it ain't falling back to you pal.
The successful closing of the SkinMedical deal changed the Allergan financials going forward to the plus side.
If you do the numbers; this deal will add to revenue and profits, and that is why knowledgeable investors, figured this out; ran the numbers and detected the imbalance that the stock price.
It was on "serious sale" at $90.13 on Dec. 31st.
Folks were quietly picking up shares on the cheap!
You can only guess at where this stock will be reasonably priced.
Perhaps that's why "insect_insight" was pounding the table on the thread for AGN $130 share price in early Dec.
There is still time left to get in 'cause there is lot more room for this baby to run....